Legal Representation
Attorney
Harold Milstein
USPTO Deadlines
Next Deadline
1519 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-09-05)
Due Date
September 05, 2029
Grace Period Ends
March 05, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
19 events| Date | Code | Type | Description |
|---|---|---|---|
| Sep 5, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Sep 5, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Jun 20, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jun 20, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| May 31, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| May 11, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| May 10, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| May 9, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| May 9, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Nov 10, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Nov 10, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Nov 10, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Nov 10, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Apr 15, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Apr 15, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Apr 15, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Feb 8, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Feb 7, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Feb 3, 2022 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Diagnostic kits comprised of reagents and assays for use in disease detection; medical diagnostic preparations for RNA-based sequencing or DNA-based sequencing
First Use Anywhere:
20200400
First Use in Commerce:
20200400
Class 044
Medical testing for diagnostic or treatment purposes; medical diagnostic testing, monitoring, and reporting services; medical testing for diagnostic or treatment purposes featuring DNA sequencing or RNA sequencing
First Use Anywhere:
20200400
First Use in Commerce:
20200400
Additional Information
Design Mark
The mark consists of stylized "KARIUS" and "TEST" words with a vertical line between them.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"TEST"